The Central Drug Standards Control Organization (CDSCO) has granted a license to Biolumpivaxin, India’s first vaccine against ...

Biovet, a subsidiary of the Bharat Biotech Group, has received approval from the CDSCO for its innovative LSD vaccine, ...

Biovet receives CDSCO license for LSD vaccine, a game-changer for animal health, developed in collaboration with ICAR.

In the last two years, around 200,000 cattle have died, millions lost their milk production capabilities due to LSD ...

Be it from tap water on a vacation, some dodgy chicken, or something the kids have brought home from school, we've almost all ...

Hyderabad: Biovet, an arm of the Bharat Biotech group that makes animal health vaccines, received a licence from the Central ...

A study was conducted to assess the safety and tolerability of the tetravalent live-attenuated dengue vaccine Qdenga®, which received marketing approval in Germany in 2022. The study evaluated vaccine ...

The Central Drug Standards Control Organization (CDSCO) has granted approval to Biolumpivaxin, India's first vaccine against ...

Attenuated Vaccines MarketThe global attenuated vaccines market is set for significant expansion, with sales projected to ...

Bharat Biotech Group has announced its Lumpy Skin Disease (LSD) vaccine for dairy cattle and buffaloes, BIOLUMPIVAXIN has ...

The infant from Indonesia was taken directly to NUH upon arrival in Singapore and isolated upon admission. Three contacts ...

The growth of the vaccine technologies market is driven by rise in prevalence of infectious diseases, growing trend towards preventive healthcare, and government immunization programs and initiatives.